back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-12-20 17:57 Tx date 2021-12-20 |
$FRX
Fennec Pharmaceuticals Inc. |
Goel, Shubh
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+37,500 vol |
37,500 | |
| Filed 2021-12-20 17:56 Tx date 2019-09-09 |
$FRX
Fennec Pharmaceuticals Inc. |
Goel, Shubh
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-20 17:39 Tx date 2021-12-20 |
$FRX
Fennec Pharmaceuticals Inc. |
Goel, Shubh
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$306,000
+75,000 vol $4.08 each |
375,000 | |
| Filed 2021-06-03 08:55 Tx date 2021-06-02 |
$FRX
Fennec Pharmaceuticals Inc. |
Goel, Shubh
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$753,000
+100,000 vol $7.53 each |
300,000 | |
| Filed 2020-05-15 17:55 Tx date 2020-05-15 |
$FRX
Fennec Pharmaceuticals Inc. |
Goel, Shubh
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$173,250
+25,000 vol $6.93 each |
200,000 | |
| Filed 2020-05-15 17:44 Tx date 2020-05-15 |
$FRX
Fennec Pharmaceuticals Inc. |
Goel, Shubh
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$173,250
+25,000 vol $6.93 each |
||
| Filed 2019-09-10 16:56 Tx date 2019-09-09 |
$FRX
Fennec Pharmaceuticals Inc. |
Goel, Shubh
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$829,500
+175,000 vol $4.74 each |
175,000 | |
| Filed 2019-09-10 16:54 Tx date 2019-09-09 |
$FRX
Fennec Pharmaceuticals Inc. |
Goel, Shubh
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-09-10 16:53 Tx date 2019-09-09 |
$FRX
Fennec Pharmaceuticals Inc. |
Goel, Shubh
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-09-10 16:32 Tx date 2019-09-09 |
$FRX
Fennec Pharmaceuticals Inc. |
Goel, Shubh
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|